InsiderClue
Insiders · Profile

WILSON TROY EDWARD

Director at PUMA BIOTECHNOLOGY · President and CEO at Kura Oncology. Filing since 11 Jun 2020. CIK 0001589597

PBYI PUMA BIOTECHNOLOGY, INC. Director · 8 trades KURA Kura Oncology, Inc. President and CEO · 24 trades
Company
Date
Role
Action
Shares
Amount
Of holding
PBYI PUMA BIOTECHNOLOGY, INC.
14 Sep 2026
Director
Sold on a plan
5,000
$45.50K
8.4%
KURA Kura Oncology, Inc.
24 Aug 2026
President and CEO
Bought
100,000
$1.24M
26.4%
KURA Kura Oncology, Inc.
17 Aug 2026
President and CEO
Bought
100,000
$1.11M
35.8%
PBYI PUMA BIOTECHNOLOGY, INC.
12 Jun 2026
Director
Sold on a plan
10,800
$77.75K
15.3%
KURA Kura Oncology, Inc.
29 Sep 2025
President and CEO
Sold at will
36,615
$327.42K
12.9%
KURA Kura Oncology, Inc.
8 Sep 2025
President & CEO
Bought
50,000
$410.15K
98.1%
KURA Kura Oncology, Inc.
13 Aug 2025
President and CEO
Bought
13,494
$89.62K
36.0%
KURA Kura Oncology, Inc.
12 Aug 2025
President and CEO
Bought
36,506
$213.58K
×38
PBYI PUMA BIOTECHNOLOGY, INC.
13 Jun 2025
Director
Sold on a plan
10,800
$36.72K
19.9%
PBYI PUMA BIOTECHNOLOGY, INC.
13 Jun 2024
Director
Sold on a plan
27,000
$89.90K
98.7%
KURA Kura Oncology, Inc.
24 Jan 2024
President and CEO
Sold at will
91,052
$1.84M
99.4%
PBYI PUMA BIOTECHNOLOGY, INC.
13 Jun 2023
Director
Sold on a plan
27,000
$93.27K
98.7%
PBYI PUMA BIOTECHNOLOGY, INC.
16 Jun 2022
Director
Sold, plan not stated
27,858
$71.97K
50.5%
PBYI PUMA BIOTECHNOLOGY, INC.
10 Jun 2021
Director
Sold, plan not stated
25,748
$292.43K
98.7%
KURA Kura Oncology, Inc.
8 Oct 2020
President and CEO
Sold, plan not stated
106,736
$3.63M
100%
KURA Kura Oncology, Inc.
8 Oct 2020
President and CEO
Sold, plan not stated
50,370
$1.71M
64.2%
KURA Kura Oncology, Inc.
7 Oct 2020
President and CEO
Sold, plan not stated
99,900
$3.20M
48.3%
KURA Kura Oncology, Inc.
7 Oct 2020
President and CEO
Sold, plan not stated
4,586
$155.92K
14.0%
KURA Kura Oncology, Inc.
6 Oct 2020
President and CEO
Sold, plan not stated
100
$3.20K
0.0%
KURA Kura Oncology, Inc.
14 Sep 2020
President and CEO
Sold, plan not stated
98,490
$2.84M
32.3%
KURA Kura Oncology, Inc.
11 Sep 2020
President and CEO
Sold, plan not stated
17,926
$501.93K
39.0%
KURA Kura Oncology, Inc.
11 Sep 2020
President and CEO
Sold, plan not stated
485
$13.58K
0.2%
KURA Kura Oncology, Inc.
10 Sep 2020
President and CEO
Sold, plan not stated
37,030
$1.04M
56.9%
KURA Kura Oncology, Inc.
10 Sep 2020
President and CEO
Sold, plan not stated
1,025
$28.70K
0.3%
KURA Kura Oncology, Inc.
8 Sep 2020
President and CEO
Sold, plan not stated
50,000
$1.30M
14.0%
KURA Kura Oncology, Inc.
25 Aug 2020
President and CEO
Sold, plan not stated
23,053
$515.79K
45.1%
KURA Kura Oncology, Inc.
24 Aug 2020
President and CEO
Sold, plan not stated
6,568
$144.77K
18.9%
KURA Kura Oncology, Inc.
19 Aug 2020
President and CEO
Sold, plan not stated
11,913
$263.20K
29.8%
KURA Kura Oncology, Inc.
18 Aug 2020
President and CEO
Sold, plan not stated
521
$11.46K
1.8%
KURA Kura Oncology, Inc.
17 Aug 2020
President and CEO
Sold, plan not stated
50,000
$1.10M
12.3%
KURA Kura Oncology, Inc.
17 Aug 2020
President and CEO
Sold, plan not stated
12,901
$283.87K
31.5%
PBYI PUMA BIOTECHNOLOGY, INC.
11 Jun 2020
Director
Sold, plan not stated
25,245
$251.69K
49.2%
32 decisions on file.